Cargando…
Prostacyclin in Intubated Patients with COVID-19 and Severe Endotheliopathy: A Multicenter, Randomized Clinical Trial
RATIONALE: The mortality in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who require mechanical ventilation remains high, and endotheliopathy has been implicated. OBJECTIVES: To determine the effect of prostacyclin infusion in mechanically ventilated patients i...
Autores principales: | Johansson, Pär I., Søe-Jensen, Peter, Bestle, Morten H., Clausen, Niels E., Kristiansen, Klaus T., Lange, Theis, Stensballe, Jakob, Perner, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886993/ https://www.ncbi.nlm.nih.gov/pubmed/34813414 http://dx.doi.org/10.1164/rccm.202108-1855OC |
Ejemplares similares
-
Efficacy and safety of iloprost in patients with septic shock‐induced endotheliopathy—Protocol for the multicenter randomized, placebo‐controlled, blinded, investigator‐initiated trial
por: Bestle, Morten H., et al.
Publicado: (2020) -
The effect of prostacyclin infusion on markers of endothelial activation and damage in mechanically ventilated patients with SARS-CoV-2 infection
por: Vigstedt, Martin, et al.
Publicado: (2022) -
The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
por: Johansson, Pär Ingemar, et al.
Publicado: (2020) -
Endotheliopathy is associated with slower liberation from mechanical ventilation: a cohort study
por: Schønemann-Lund, Martin, et al.
Publicado: (2022) -
Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism
por: Johansson, PärIngemar, et al.
Publicado: (2017)